Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin

ASIA unversity > 醫學暨健康學院 > 生物科技學系 > 期刊論文 > Item 310904400/4501

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/4501

题名:	Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin
作者:	Krstenansky JL;Broersma RJ;Owen TJ;Payne MH;Yates MT;Mao SJT
贡献者:	Department of Biotechnology
日期:	1990-04
上传时间:	2009-11-26 01:43:28 (UTC+0)
出版者:	Asia University
摘要:	MDL 28,050 is a decapeptide antithrombin agent that inhibits alpha-thrombin-induced fibrin clot formation by binding to a non-catalytic site on alpha-thrombin. It is the result of chemical and structural optimization of a functional domain of the leech anticoagulant, hirudin. In contrast to the contention that the polyanionic nature of this C-terminal functional domain governs its interaction with alpha-thrombin, systematic study of this region has shown the importance of the lipophilic residues for providing the functionality necessary for potent binding to alpha-thrombin. The development of MDL 28,050 and other effective antithrombin agents are outlined through the description of the structure-activity relationships (SAR) for these peptides. These peptides are effective in a variety of in vitro and in vivo models of thrombosis.
關聯:	Thrombosis and Haemostasis 63(2):208-14
显示于类别:	[生物科技學系] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
		0Kb	Unknown	551	检视/开启
310904400-4501 .doc		30Kb	Microsoft Word	297	检视/开启

在ASIAIR中所有的数据项都受到原著作权保护.